✦ LIBER ✦

PCV39 ECONOMIC EVALUATION OF THE MEDENOX (PROPHYLAXIS IN MEDICAL PATIENTS WITH ENOXAPARIN) TRIAL FROM THE PERSPECTIVE OF HOSPITALS IN GERMANY: RESULTS OF A SUBGROUP ANALYSIS

✍ Scribed by PK Schädlich; M Kentsch; M Weber; W Kämmerer; V Nadipelli; E Huppertz; JG Brecht

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV17: ECONOMIC EVALUATION OF ENOXAPARIN

✍ M Nuijten; P Berto; J Kosa; V Nadipelli 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PCV37 ECONOMIC EVALUATION OF TRANSESOPHA

✍ PK Schadlich; W Lehmacher; E Huppertz; R Grewe; JG Brecht 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCV27 ECONOMIC EVALUATION OF NEBIVOLOL C

✍ G Yao; N Freemantle; M Flather; P Tharmanathan; A Coats; PA Poole-Wilson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCV45 Health Economic Evaluation of Tica

✍ L. Delgado-Ortega; J.L. López-Sendón; M. Heras Fortuny; C. Alvarez Sanz; E. Niko 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Multinational economic evaluation of val

✍ Shelby D Reed; Joëlle Y Friedman; Eric J Velazquez; Ari Gnanasakthy; Robert M Ca 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A cost-minimisation analysis comparing m

✍ Lloyd, A.; Holman, A.; Evers, T. 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 321 KB